A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
|Articles|August 27, 2020
Did COVID-19 Fears Lead to Fewer Stroke Admissions?
Author(s)Grant M. Gallagher
Hospital admissions for stroke fell by nearly a third during March and April 2020 alone when compared with those months in 2019.
Advertisement
While it will take time to assess the full spectrum of effects, the impacts of COVID-19 mass quarantine measures on
Utilization of the health system is down in general. Childhood vaccination rates have plummeted, for example, along with cancer screenings.
According to a study team publishing in
It is believed that at the peak of lockdown policies, many patients underused emergency services or avoided the medical system altogether due to fear of SARS-CoV-2.
Related Video:
In order to examine the phenomenon in the context of stroke, the study team retrospectively compared total weekly hospital admissions, including transfers, in cities with COVID-19 outbreaks during the first wave of the US pandemic: New York City, Boston, Seattle, and Providence.
Pandemic data were compared with data from 2018-2019.
The team also used available data on emergency department stroke alerts.
Analysis of the results showed that compared with the same period in 2018-19, stroke admissions as well as emergency department stroke alerts fell. The declines coincided with stay-at-home recommendations introduced in late March.
The most substantive fall in stroke admissions took place between March 23 and April 19 2020, when there were 281 in total, compared with 410 total in the same period of 2019.
"Our findings underscore the indirect effects of this pandemic. Public health officials, hospital systems and healthcare providers must continue to encourage patients with stroke to seek acute care during this crisis,” study authors wrote.
Advertisement
Related to this article
In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.
In its second disease cluster this summer, city officials are cleaning building towers in the South Bronx amidst an ongoing investigation and are rolling out measures to prevent future Legionnaires' cases.
The death was reported in Jefferson County where the coroner released a statement announcing it was in an unvaccinated woman.
FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax's partners, all reformulated to target the XFG variant, giving clinicians several options ahead of the fall respiratory virus season.
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Advertisement
Advertisement
Trending on Contagion Live
1
Recent Guideline Updates in the Management of Urinary Tract Infections
2
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
3
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
4
Measles Update: October 2, 2026
5